The trademark application Letrozole LEBE was filed by LABORATORIOS FARMACEUTICOS ROVI, S.A., a corporation established under the laws of the Kingdom of Spain (the "Applicant"). The application was published for oppositions on June 1, 2023, and it was registered by office on September 8, 2023 without any oppositions.
The application was filed in Spanish (English was selected as the second language).
Goods And Services
The mark was filed in class 42 with following description of goods:
Clinical research for breast cancer treatment
Clinical research of pharmaceuticals for use in breast cancer treatment
Medical and pharmaceutical research services in the field of breast cancer
Scientific research for medical and clinical purposes in the field of breast cancer.